SN-38
Template:Chembox SN-38 is an antineoplastic drug. It is the active metabolite of irinotecan (an analog of camptothecin - a topoisomerase I inhibitor) but has 1000 times more activity than irinotecan itself. In vitro cytotoxicity assays show that the potency of SN-38 relative to irinotecan varies from 2- to 2000-fold.[1]
SN38 is formed via hydrolysis of irinotecan by carboxylesterases and metabolized via glucuronidation by UGT1A1.
The variant of UGT1A1 in ~10% of Caucasians which leads to poor metabolism of SN-38 predicts irinotecan toxicity, as it is then less easily excreted from the body in its SN-38 glucuronide form.[2]
SN-38 and its glucuronide are lost into the bile and intestines. It can cause the symptoms of diarrhoea and myelosuppression experienced by ~25% of the patients administered irinotecan.
Interactive pathway map
Template:IrinotecanPathway WP229
See also
- NK012, a nanodevice formulation of SN-38
- Sacituzumab govitecan, an antibody-drug conjugate that uses SN-38 as the cytotoxic drug.
References
<templatestyles src="Reflist/styles.css" />
Script error: No such module "Check for unknown parameters".